| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |